Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Gammaretroviral vector encoding a fluorescent marker to facilitate detection of reprogrammed human fibroblasts during iPSC generation.

Srinivasakumar N, Zaboikin M, Tidball AM, Aboud AA, Neely MD, Ess KC, Bowman AB, Schuening FG.

PeerJ. 2013 Dec 10;1:e224. doi: 10.7717/peerj.224. eCollection 2013.

2.

Stem cell therapy for cardiac disease: what can be learned from oncology.

Naftilan AJ, Schuening FG.

Heart Fail Clin. 2011 Jul;7(3):345-55. doi: 10.1016/j.hfc.2011.03.006. Epub 2011 May 14. Review.

PMID:
21749886
3.

Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD.

Clark WB, Brown-Gentry KD, Crawford DC, Fan KH, Snavely J, Chen H, Savani BN, Kassim A, Greer JP, Schuening FG, Engelhardt BG, Jagasia MH.

Blood. 2011 Jul 28;118(4):1140-4. doi: 10.1182/blood-2010-09-310011. Epub 2011 May 31.

PMID:
21628416
4.

High-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes.

Engelhardt BG, Holland DW, Brandt SJ, Chinratanalab W, Goodman SA, Greer JP, Jagasia MH, Kassim AA, Morgan DS, Ruffner KL, Schuening FG, Wolff S, Bitting R, Sulur P, Stein RS.

Leuk Lymphoma. 2007 Sep;48(9):1728-35.

PMID:
17786708
5.

Pegfilgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplant: phase II study.

Jagasia MH, Greer JP, Morgan DS, Mineishi S, Kassim AA, Ruffner KL, Chen H, Schuening FG.

Bone Marrow Transplant. 2005 Jun;35(12):1165-9.

PMID:
15880129
6.

Graft-versus-host disease in mini-transplant.

Mineishi S, Schuening FG.

Leuk Lymphoma. 2004 Oct;45(10):1969-80. Review.

PMID:
15370240
7.

Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysis.

Vusirikala M, Wolff SN, Stein RS, Brandt SJ, Morgan DS, Greer JP, Schuening FG, Dummer JS, Goodman SA.

Bone Marrow Transplant. 2001 Aug;28(3):265-70.

8.

Human gene marker/therapy clinical protocols.

Rosenberg SA, Blaese RM, Brenner MK, Deisseroth AB, Ledley FD, Lotze MT, Wilson JM, Nabel GJ, Cornetta K, Economou JS, Freeman SM, Riddell SR, Brenner M, Oldfield E, Gansbacher B, Dunbar C, Walker RE, Schuening FG, Roth JA, Crystal RG, Welsh MJ, Culver K, Heslop HE, Simons J, Wilmott RW, Boucher RC, Siegler HF, Barranger JA, Karlsson S, Kohn D, Galpin JE, Raffel C, Hesdorffer C, Ilan J, Cassileth P, O'Shaughnessy J, Kun LE, Das TK, Wong-Staal F, Sobol RE, Haubrich R, Sznol M, Rubin J, Sorcher EJ, Rosenblatt J, Walker R, Brigham K, Vogelzang N, Hersh E, Eck SL.

Hum Gene Ther. 2000 Apr 10;11(6):919-79. No abstract available.

PMID:
10779168
9.

Human gene marker/therapy clinical protocols.

Rosenberg SA, Blaese RM, Brenner MK, Deisseroth AB, Ledley FD, Lotze MT, Wilson JM, Nabel GJ, Cornetta K, Economou JS, Freeman SM, Riddell SR, Oldfield E, Gansbacher B, Dunbar C, Walker RE, Schuening FG, Roth JA, Crystal RG, Welsh MJ, Culver K, Heslop HE, Simons J, Wilmott RW, Habib NA, et al.

Hum Gene Ther. 1999 Dec 10;10(18):3067-123. No abstract available.

PMID:
10609664
10.
12.

Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity.

Mineishi S, Longo WL, Atkinson ME, Smith EP, Hamielec M, Wiersma SR, Kinsella TJ, Schuening FG.

Bone Marrow Transplant. 1999 Jun;23(12):1217-22.

13.

Dose rate-dependent marrow toxicity of TBI in dogs and marrow sparing effect at high dose rate by dose fractionation.

Storb R, Raff RF, Graham T, Appelbaum FR, Deeg HJ, Schuening FG, Sale G, Seidel K.

Biol Blood Marrow Transplant. 1999;5(3):155-61.

14.

Poor expression of MDR1 transgene in HeLa cells by bicistronic Moloney murine leukemia virus-based vector.

Zaboikin MM, Schuening FG.

Hum Gene Ther. 1998 Oct 10;9(15):2263-75.

PMID:
9794210
15.

Dose rate-dependent sparing of the gastrointestinal tract by fractionated total body irradiation in dogs given marrow autografts.

Storb R, Raff R, Deeg HJ, Graham T, Appelbaum FR, Schuening FG, Shulman H, Seidel K, Leisenring W.

Int J Radiat Oncol Biol Phys. 1998 Mar 1;40(4):961-6.

PMID:
9531382
16.

Human gene marker/therapy clinical protocols.

Rosenberg SA, Blaese RM, Brenner MK, Deisseroth AB, Ledley FD, Lotze MT, Wilson JM, Nabel GJ, Cornetta K, Economou JS, Freeman SM, Riddell SR, Oldfield E, Gansbacher B, Dunbar C, Walker RE, Schuening FG, Roth JA, Crystal RG, Welsh MJ, Culver K, Heslop HE, Simons J, Wilmott RW, Boucher RC, et al.

Hum Gene Ther. 1997 Dec 10;8(18):2301-38. No abstract available.

PMID:
9449381
17.

Effect of recombinant canine stem cell factor, a c-kit ligand, on hematopoietic recovery after DLA-identical littermate marrow transplants in dogs.

Schuening FG, von Kalle C, Kiem HP, Appelbaum FR, Deeg HJ, Pepe M, Gooley T, Graham TC, Hackman RC, Storb R.

Exp Hematol. 1997 Nov;25(12):1240-5.

PMID:
9357967
18.

In vivo radioprotective effect of AcSDKP on canine myelopoiesis.

Deeg HJ, Seidel K, Hong DS, Yu C, Huss R, Schuening FG, Ewel CH, Storb R.

Ann Hematol. 1997 Mar;74(3):117-22.

PMID:
9111424
19.

An anti-CD44 antibody does not enhance engraftment of DLA-identical marrow after low-dose total body irradiation.

Sandmaier BM, Storb R, Liu Y, Santos EB, Bryant E, Schuening FG, Deeg HJ, Seidel K, Graham T.

Transpl Immunol. 1996 Dec;4(4):271-4.

PMID:
8972556
20.

Human gene marker/therapy clinical protocols.

Rosenberg SA, Blaese RM, Brenner MK, Deisseroth AB, Ledley FD, Lotze MT, Wilson JM, Nabel GJ, Cornetta K, Economou JS, Freeman SM, Riddell SR, Oldfield E, Gansbacher B, Dunbar C, Walker RE, Schuening FG, Roth JA, Crystal RG, Welsh MJ, Culver K, Heslop HE, Simons J, Wilmott RW, Tiberghien P, et al.

Hum Gene Ther. 1996 Dec 1;7(18):2287-313. No abstract available.

PMID:
8953320
21.
22.

Failure of recombinant stem cell factor to enhance engraftment of L-leucyl-L-leucine methyl ester treated canine marrow after irradiation.

Kiem HP, Leisenring W, Raff R, Deeg HJ, Schuening FG, Appelbaum FR, Storb R.

Blood. 1996 Sep 1;88(5):1896-7. No abstract available.

PMID:
8781451
23.

Human gene marker/therapy clinical protocols.

Rosenberg SA, Blaese RM, Brenner MK, Deisseroth AB, Ledley FD, Lotze MT, Wilson JM, Nabel GJ, Cornetta K, Economou JS, Freeman SM, Riddell SR, Oldfield E, Gansbacher B, Dunbar C, Walker RE, Schuening FG, Roth JA, Crystal RG, Welsh MJ, Culver K, Heslop HE, Simons J, Wilmott RW, Aebischer P, et al.

Hum Gene Ther. 1996 Aug 20;7(13):1621-47. No abstract available.

PMID:
8864763
24.

Allogeneic transplant of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors.

Sandmaier BM, Storb R, Santos EB, Krizanac-Bengez L, Lian T, McSweeney PA, Yu C, Schuening FG, Deeg HJ, Graham T.

Blood. 1996 Apr 15;87(8):3508-13.

PMID:
8605371
25.

Long-term persistence of canine hematopoietic cells genetically marked by retrovirus vectors.

Kiem HP, Darovsky B, Von Kalle C, Goehle S, Graham T, Miller AD, Storb R, Schuening FG.

Hum Gene Ther. 1996 Jan;7(1):89-96.

PMID:
8825872
26.

DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment.

Yu C, Storb R, Mathey B, Deeg HJ, Schuening FG, Graham TC, Seidel K, Burnett R, Wagner JL, Shulman H, Sandmaier BM.

Blood. 1995 Dec 1;86(11):4376-81.

PMID:
7492799
27.

Development of a clonality assay for canine hematopoietic stem cells.

Wagner LA, Kiem HP, McSweeney P, Schuening FG, Storb R, Ostrander EA.

Blood. 1995 Oct 15;86(8):3265-7. No abstract available.

PMID:
7579426
28.

Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: increased destruction of circulating platelets.

Nash RA, Burstein SA, Storb R, Yang W, Abrams K, Appelbaum FR, Boone T, Deeg HJ, Durack LD, Schuening FG.

Blood. 1995 Sep 1;86(5):1765-75.

PMID:
7655007
29.

Corticotropin releasing factor with or without methotrexate for prevention of graft-versus-host disease in DLA-nonidentical unrelated canine marrow grafts.

Yu C, Storb R, Braude I, Deeg HJ, Schuening FG, Huss R, Graham TC.

Transplantation. 1995 Aug 27;60(4):384-6. No abstract available.

PMID:
7652769
30.

Failure of interleukin-1 and granulocyte-macrophage colony-stimulating factor to enhance allogeneic marrow engraftment and survival in irradiated dogs.

Mathey B, Yu C, Sandmaier BM, Deeg HJ, Graham T, Schuening FG, Nash RA, Stor B.

Blood. 1995 Jul 15;86(2):833-4. No abstract available.

PMID:
7606016
31.

DLA-identical marrow grafts after low-dose total-body irradiation. Addition of viable donor peripheral blood mononuclear cells does not enhance engraftment.

Storb R, Raff RF, Deeg HJ, Graham TC, Schuening FG, Shulman H, Bryant E.

Transplantation. 1995 May 27;59(10):1481-2. No abstract available.

PMID:
7770937
32.

Effects of rhIL-11 on normal dogs and after sublethal radiation.

Nash RA, Seidel K, Storb R, Slichter S, Schuening FG, Appelbaum FR, Becker AB, Bolles L, Deeg HJ, Graham T, et al.

Exp Hematol. 1995 May;23(5):389-96.

PMID:
7720811
33.

Myelosuppressive conditioning improves autologous engraftment of genetically marked hematopoietic repopulating cells in dogs.

Barquinero J, Kiem HP, von Kalle C, Darovsky B, Goehle S, Graham T, Seidel K, Storb R, Schuening FG.

Blood. 1995 Mar 1;85(5):1195-201.

PMID:
7532034
34.

DLA-identical bone marrow grafts after low-dose total body irradiation: the effect of canine recombinant hematopoietic growth factors.

Storb R, Raff RF, Appelbaum FR, Deeg HJ, Graham TC, Schuening FG, Shulman H, Yu C, Bryant E, Burnett R, et al.

Blood. 1994 Nov 15;84(10):3558-66.

PMID:
7524741
35.

Increased gene transfer into human hematopoietic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector.

von Kalle C, Kiem HP, Goehle S, Darovsky B, Heimfeld S, Torok-Storb B, Storb R, Schuening FG.

Blood. 1994 Nov 1;84(9):2890-7.

PMID:
7524756
36.

Transplantation of retrovirus-transduced canine keratinocytes expressing the beta-galactosidase gene.

Stockschl├Ąder MA, Schuening FG, Graham TC, Storb R.

Gene Ther. 1994 Sep;1(5):317-22.

PMID:
7584097
37.

Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine littermates for DLA-identical marrow grafts.

Storb R, Raff RF, Appelbaum FR, Deeg HJ, Graham TC, Schuening FG, Sale G, Bryant E, Seidel K.

Blood. 1994 Jun 1;83(11):3384-9.

PMID:
8193376
38.

Effect of recombinant canine granulocyte-macrophage colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation.

Nash RA, Schuening FG, Seidel K, Appelbaum FR, Boone T, Deeg HJ, Graham TC, Hackman R, Sullivan-Pepe M, Storb R.

Blood. 1994 Apr 1;83(7):1963-70.

PMID:
8142662
39.

Hematopoietic growth factors after allogeneic marrow transplantation in animal studies and clinical trials.

Schuening FG, Nemunaitis J, Appelbaum FR, Storb R.

Bone Marrow Transplant. 1994;14 Suppl 4:S74-7. Review.

PMID:
7728131
40.

Studies of the use of L-leucyl-L-leucine methyl ester in canine allogeneic marrow transplantation.

Raff RF, Severns EM, Storb R, Graham TC, Sale G, Schuening FG, Appelbaum FR.

Transplantation. 1993 Jun;55(6):1244-9.

PMID:
8516809
41.

Marrow toxicity of fractionated vs. single dose total body irradiation is identical in a canine model.

Storb R, Raff RF, Graham T, Appelbaum FR, Deeg HJ, Schuening FG, Shulman H, Pepe M.

Int J Radiat Oncol Biol Phys. 1993 May 20;26(2):275-83.

PMID:
7684038
42.

Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation.

Schuening FG, Appelbaum FR, Deeg HJ, Sullivan-Pepe M, Graham TC, Hackman R, Zsebo KM, Storb R.

Blood. 1993 Jan 1;81(1):20-6.

PMID:
7678065
43.

Specific marrow ablation before marrow transplantation using an aminophosphonic acid conjugate 166Ho-EDTMP.

Appelbaum FR, Brown PA, Sandmaier BM, Storb R, Fisher DR, Shulman HM, Graham TC, Schuening FG, Deeg HJ, Bianco JA, et al.

Blood. 1992 Sep 15;80(6):1608-13.

PMID:
1520886
44.

Gene transfer into hematopoietic stem cells.

Schuening FG.

Curr Top Microbiol Immunol. 1992;177:237-45. Review. No abstract available.

PMID:
1353432
45.

Retrovirus-mediated gene transduction into long-term repopulating marrow cells of dogs.

Schuening FG, Kawahara K, Miller AD, To R, Goehle S, Stewart D, Mullally K, Fisher L, Graham TC, Appelbaum FR, et al.

Blood. 1991 Nov 15;78(10):2568-76.

PMID:
1726705
46.

Late failure of autologous marrow grafts in lethally irradiated dogs given anti-class II monoclonal antibody.

Greinix HT, Ladiges WC, Graham TC, Maslan S, Raff RF, Sandmaier BM, Appelbaum FR, Schuening FG, Deeg HJ, Storb R.

Blood. 1991 Oct 15;78(8):2131-8.

PMID:
1912590
47.

Biochemical characterization of a unique canine myeloid antigen.

Sandmaier BM, Schuening FG, Bianco JA, Rosenman SJ, Bernstein I, Goehle S, Storb R, Appelbaum FR.

Leukemia. 1991 Feb;5(2):125-30.

PMID:
2020194
48.

Treatment of marrow donor blood products with gamma-irradiation prevents transfusion-induced sensitization to DLA-identical marrow grafts.

Storb R, Bean MA, Appelbaum FR, Schuening FG, Graham TC, Raff RF.

Transplant Proc. 1991 Feb;23(1 Pt 2):1697-8. No abstract available.

PMID:
1824901
49.

Transfusion of autologous cytotoxic cells leads to failure of unrelated, DLA-nonidentical marrow grafts.

Loughran TP Jr, Raff RF, Graham TC, Appelbaum FR, Schuening FG, Sale GE, Storb R.

Exp Hematol. 1990 Nov;18(10):1126-31.

PMID:
2209768
50.

Recombinant human granulocyte colony-stimulating factor accelerates hematopoietic recovery after DLA-identical littermate marrow transplants in dogs.

Schuening FG, Storb R, Goehle S, Graham TC, Hackman R, Mori M, Souza LM, Appelbaum FR.

Blood. 1990 Aug 1;76(3):636-40.

PMID:
1696148

Supplemental Content

Loading ...
Support Center